NAIR ANILKUMAR GOPINADHAN,KIM SEONG HEON,ROSENBLUM STUART B,WONG MICHAEL K C,ZENG QINGBEI,KEERTIKAR KERRY M,KOZLOWSKI JOSEPH A,SELYUTIN OLEG B,YU WENSHENG
申请号：
ZA201206716
公开号：
ZA201206716B
申请日:
2012.09.07
申请国别(地区):
ZA
年份:
2013
代理人:
摘要：
The present invention relates to novel Fused Tricyclic Silyl Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, M1, X1 and X2 are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Silyl Compound, and methods of using the Fused Tricyclic Silyl Compounds for treating or preventing HCV infection in a patient.
